Hints for future investigations are represented by incretins, gliflozins and PCSK9i which, despite the lack of studies in cirrhotic patients, seem to reduce CVD death and/or hospitalization for HF in the general population, representing a starting point for further studies in which sex and gender should be adequately represented. This evidence concerns the gene GCG and hydrops fetalis.